Acuta Capital Partners, LLC

Acuta Capital Partners, LLC reported 35 holdings worth US$132M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Acuta Capital Partners, LLC reported 35 holdings worth US$132M as of Sep 30, 2026. Largest: Praxis Precision Medicines, Inc., Whitehawk Therapeutics, Inc. and Tango Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
35
Value as reported
US$132M

The filing in full

CompanySharesValue as reported% of portfolio
Praxis Precision Medicines, Inc.84,193US$24.5M18.6%
Whitehawk Therapeutics, Inc.4.69MUS$17.6M13.4%
Tango Therapeutics, Inc.410KUS$10.2M7.8%
4D Molecular Therapeutics, Inc.535KUS$7.66M5.8%
argenx SE5,558US$5.33M4.0%
ArriVent BioPharma, Inc.171KUS$5.17M3.9%
Surrozen, Inc.153KUS$4.91M3.7%
Vogenx Inc213KUS$4.86M3.7%
Bright Minds Biosciences Inc.93,152US$4.64M3.5%
Ocular Therapeutix, Inc.575KUS$4.41M3.3%
Silence Therapeutics PLC394KUS$4.3M3.3%
Taysha Gene Therapies, Inc.692KUS$3.37M2.6%
Avalyn Pharma Inc.115KUS$3.27M2.5%
Avalo Therapeutics, Inc.186KUS$2.86M2.2%
Opus Genetics, Inc.514KUS$2.49M1.9%
Minerva Neurosciences, Inc730KUS$2.44M1.9%
LB Pharmaceuticals Inc52,718US$2.02M1.5%
Artiva Biotherapeutics, Inc.260KUS$1.85M1.4%
Amylyx Pharmaceuticals, Inc.62,956US$1.83M1.4%
Revolution Medicines, Inc.8,237US$1.69M1.3%
Roivant Sciences Ltd.41,535US$1.52M1.2%
Design Therapeutics, Inc.115KUS$1.45M1.1%
United Therapeutics Corporation2,240US$1.21M0.92%
Contineum Therapeutics, Inc.89,826US$1.21M0.92%
ORIC Pharmaceuticals, Inc.87,918US$1.18M0.90%
Erasca, Inc.67,541US$990K0.75%
AN2 Therapeutics, Inc.142KUS$756K0.57%
Adial Pharmaceuticals, Inc130KUS$521K0.40%
Sutro Biopharma, Inc.25,290US$407K0.31%
Equillium, Inc.183KUS$297K0.23%
Compass Therapeutics, Inc.251KUS$261K0.20%
Stoke Therapeutics, Inc.5,771US$150K0.11%

Source

Download original · View original at SEC

Related